company background image
LLAI logo

LungLife AI AIM:LLAI Stock Report

Last Price

UK£0.31

Market Cap

UK£9.5m

7D

5.1%

1Y

-60.0%

Updated

27 Mar, 2024

Data

Company Financials +

LLAI Stock Overview

LungLife AI, Inc., a diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People’s Republic of China.

LLAI fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

LungLife AI, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for LungLife AI
Historical stock prices
Current Share PriceUK£0.31
52 Week HighUK£1.42
52 Week LowUK£0.19
Beta-0.12
1 Month Change-26.19%
3 Month Change-15.07%
1 Year Change-60.00%
3 Year Changen/a
5 Year Changen/a
Change since IPO-84.88%

Recent News & Updates

Recent updates

We Think LungLife AI (LON:LLAI) Needs To Drive Business Growth Carefully

Dec 08
We Think LungLife AI (LON:LLAI) Needs To Drive Business Growth Carefully

We Think LungLife AI (LON:LLAI) Needs To Drive Business Growth Carefully

Aug 12
We Think LungLife AI (LON:LLAI) Needs To Drive Business Growth Carefully

Here's Why LungLife AI (LON:LLAI) Must Use Its Cash Wisely

Feb 09
Here's Why LungLife AI (LON:LLAI) Must Use Its Cash Wisely

Here's Why We're A Bit Worried About LungLife AI's (LON:LLAI) Cash Burn Situation

Oct 08
Here's Why We're A Bit Worried About LungLife AI's (LON:LLAI) Cash Burn Situation

Shareholder Returns

LLAIGB BiotechsGB Market
7D5.1%0.2%2.3%
1Y-60.0%-27.3%2.7%

Return vs Industry: LLAI underperformed the UK Biotechs industry which returned -27.5% over the past year.

Return vs Market: LLAI underperformed the UK Market which returned 3.7% over the past year.

Price Volatility

Is LLAI's price volatile compared to industry and market?
LLAI volatility
LLAI Average Weekly Movement14.8%
Biotechs Industry Average Movement7.9%
Market Average Movement4.8%
10% most volatile stocks in GB Market11.3%
10% least volatile stocks in GB Market2.5%

Stable Share Price: LLAI's share price has been volatile over the past 3 months.

Volatility Over Time: LLAI's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of UK stocks.

About the Company

FoundedEmployeesCEOWebsite
200915Paul Paganohttps://lunglifeai.com

LungLife AI, Inc., a diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People’s Republic of China. It engages in developing LungLB, a blood-based test to stratify cancerous and benign lung nodules identified by CT scan. The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019.

LungLife AI, Inc. Fundamentals Summary

How do LungLife AI's earnings and revenue compare to its market cap?
LLAI fundamental statistics
Market capUK£9.50m
Earnings (TTM)-UK£4.70m
Revenue (TTM)UK£29.28k

324.6x

P/S Ratio

-2.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LLAI income statement (TTM)
RevenueUS$37.00k
Cost of RevenueUS$0
Gross ProfitUS$37.00k
Other ExpensesUS$5.98m
Earnings-US$5.94m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

Apr 04, 2024

Earnings per share (EPS)-0.19
Gross Margin100.00%
Net Profit Margin-16,064.86%
Debt/Equity Ratio0%

How did LLAI perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.